Coca-Cola Europacific Partners vs Coca-Cola Consolidated
CCEP and COKE side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCEP and COKE compare
Coca-Cola Consolidated grew revenue faster over the last twelve months (10.7% versus 2.3% for Coca-Cola Europacific Partners).
Coca-Cola Europacific Partners keeps more of each dollar of sales as profit, with a net margin of 9.3% compared with 7.2% at Coca-Cola Consolidated.
Coca-Cola Consolidated pays a dividend yielding 0.48%; Coca-Cola Europacific Partners does not pay one.
Coca-Cola Consolidated scores higher on the StockData Score (15 against 10 for Coca-Cola Europacific Partners), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCEP | COKE |
|---|---|---|
| Size and price | ||
| Market cap | – | $14.0B |
| Share price | $113.22 | $210.30 |
| Change, 1 year | 27.8% | 64.3% |
| Change, 5 years | 105% | 385% |
| Beta (5Y) | 0.52 | 0.53 |
| Employees | 39K | 17K |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 6 | 6 |
| Health score | 2 | 3 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/S | – | 1.8× |
| EV/EBITDA | – | 13.6× |
| P/FCF | – | 21.7× |
| FCF yield | – | 4.6% |
| Fair value | – | $229.58 |
| Margin of safety | – | 8.4% |
| Growth | ||
| Revenue growth (TTM) | 2.3% | 10.7% (better) |
| Revenue growth, 5Y average | 14.5% (better) | 7.6% |
| Net income growth (TTM) | 37.0% (better) | −6.1% |
| EPS growth (TTM) | 38.3% | – |
| EPS growth, 5Y average | 31.3% | – |
| Profitability | ||
| Gross margin | 35.6% | 39.1% (better) |
| Operating margin | 13.4% (better) | 13.0% |
| Net margin | 9.3% (better) | 7.2% |
| FCF margin | 10.5% (better) | 8.4% |
| Return on equity | 23.8% | 97.3% (better) |
| Return on invested capital | 12.0% | 39.8% (better) |
| Financial health | ||
| Debt / equity | 1.36 | – |
| Net debt / EBITDA | 3.50 | 1.95 (better) |
| Interest coverage | 9.1× | – |
| Current ratio | 0.80 | 1.21 (better) |
| Altman Z-score | – | 4.07 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.48% |
| Payout ratio | – | 13.9% |
| Shareholder yield | – | 0.48% |
| Ownership | ||
| Held by institutions | 34.4% | 62.3% |
| Held by insiders | 17.6% | 15.9% |
| Insider net buying, 12 months | – | −$2.4B |
| Short interest, % of float | – | 4.9% |
Go deeper
- CCEP stock overview
- CCEP income statement
- CCEP valuation and score
- COKE stock overview
- COKE income statement
- COKE valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.